-
Mashup Score: 2
Journal of Neuro-Oncology – Few studies have evaluated the health-related quality of life (HRQoL) of patients with diffuse low-grade glioma (LGG) during a clinical and radiological monitoring…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 18
Journal of Neuro-Oncology – Chimeric antigen receptor (CAR) T cell therapy is an exciting modality of immunotherapy that has revolutionized the treatment of hematologic malignancies. However,…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Grewal et al @MGHpathology @MGHNeurosurg demonstrated in an excellent review article that the rapid evolution of investigational CAR T cell therapies portends great potential for the future of glioma treatment. #JNO Read more: https://t.co/9uJdDcbMSB https://t.co/hfHaqTQPkJ
-
-
Mashup Score: 8
Journal of Neuro-Oncology – Glioblastoma (GBM) that presents as leptomeningeal disease (LMD) is extremely rare and fatal. Limited data are available regarding incidence, clinical presentation, and…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Mondia et al. @arasthagiri @UVAneurosurg @UVANeurology reported the first case of GBM presenting exclusively as LMD without a primary lesion and provided diagnostic and therapeutic recommendations. #JNO Read more: https://t.co/2LA2c8rEN0 https://t.co/fPE106jQZO
-
-
Mashup Score: 4Journal of Neuro-Oncology Editorial Newsletter - 10 day(s) ago
Welcome to the Journal of Neuro-Oncology newsletter for 2024. In this newsletter, we would like to share with you some journal highlights and current developments for Journal of Neuro-Oncology.
Source: sway.cloud.microsoftCategories: General Medicine News, Oncologists1Tweet-
We are pleased to present our latest newsletter. We have highlighted a few of the many accomplishments the journal has achieved in 2024! #JNO Link: https://t.co/TiYparMzir
-
-
Mashup Score: 8Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutant - 12 day(s) ago
Journal of Neuro-Oncology – H3 histone 27 lysine (H3K27) trimethylation (H3K27me3), which is catalyzed by enhancer of zeste homolog 2 (EZH2), regulates gene expression through epigenetic…
Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet-
Onishi et al. showed that double positivity for H3K27me3 & EZH2 may signal poor prognosis in astrocytoma, IDH-mutant. These markers could help refine risk stratification and patient management. #JNO Read more: https://t.co/qeuSPaWiby https://t.co/uqV0IQAj2g
-
-
Mashup Score: 10Patterns of failure after stereotactic radiosurgery for brain metastases from small cell lung cancer: outcomes in the immunotherapy era - 14 day(s) ago
Journal of Neuro-Oncology – Small cell lung cancer (SCLC) is known to have high rates of development of brain metastases. Standard treatment has been whole brain radiation therapy (WBRT) but the…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Marwaha et al. @alex_marwaha @ahnneuroscience showed a similar distant brain failure rate after SRS for brain metastases from small cell lung cancer to those of NSCLC in the immunotherapy era. #JNO Read more: https://t.co/f2XoptAQnZ https://t.co/5mKndOBGA5
-
-
Mashup Score: 7
Journal of Neuro-Oncology – Prophylactic insertion of an external ventricular drainage (EVD) prior to the resection of posterior fossa metastases (PFMs) is a common approach to address…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Shabo et al @UniklinikBonn reported pre-operative risk factors for the occurrence of post-operative hydrocephalus following surgery of brain metastases in the posterior fossa. #JNO Read more: https://t.co/cfVo4evfXG https://t.co/50jk5CSJJb
-
-
Mashup Score: 9A four-hit mechanism is sufficient for meningioma development - 18 day(s) ago
Journal of Neuro-Oncology – Meningiomas are central nervous system tumors whose incidence increases with age. Benign meningioma pathogenesis involves germline or somatic mutation of target genes,…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Devarajan et al @AlexDevarajan @ShrivastavaMD @MountSinaiNeuro analyzed 222,509 cases and showed that four mutations are uniquely required to develop benign meningiomas. #JNO Read more: https://t.co/5JDrEtNOIs https://t.co/wbQL9BFoFI
-
-
Mashup Score: 2Higher isoform of hnRNPA1 confer Temozolomide resistance in U87MG & LN229 glioma cells - 20 day(s) ago
Journal of Neuro-Oncology – Gliblastoma is a malignant brain tumor; despite available treatment modalities, the tumor reoccurrence rate persist in the currently prescribed Temozolomide…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Bhardwaj et al @weareAUD showed that targeting higher isoform Var2 of hnRNPA1 induces chemosensitization in MGMT-expressed U87MG and MGMT-non-expressed LN229 temozolomide-resistant cells. #JNO Read more: https://t.co/KfW4nOZqxE https://t.co/ALdnjsCau8
-
-
Mashup Score: 36
Journal of Neuro-Oncology – There is an unmet need for new treatments for many central nervous system tumors. An expanding body of research supports the use of laser interstitial thermal therapy…
Source: link.springer.comCategories: General Medicine News, Oncologists1Tweet-
Haskell-Mendoza et al @AdenMendoza @PeterFecci @Dukeneurosurg provide a review of emerging data in indications, imaging, and adjunctive therapies for LITT. #JNO Read more: https://t.co/ZD1o85bapm https://t.co/HduGy6MrdG
-
Obara et al. assessed the quality of life of patients with diffuse low-grade glioma and showed significantly lower cognitive, emotional, role, and social functioning than the normative population. #JNO Read more:https://t.co/bN4MWjxrW6 https://t.co/aM5JijYort